Dorf L, Brard L, Koto K, Bosenberg M, Illyene S, Singh R, Kim K, Saulnier Sholler G. RKS-2-62 is more effective and less toxic than its parent drug Nifurtimox for Neuroblastoma. AACR 2008 Annual Meeting, San Diego, CA
Dorf L, Brard L, Koto K, Bosenberg M, Illyene S, Singh R, Kim K, Saulnier Sholler G. RKS-2-62 is more effective and less toxic than its parent drug Nifurtimox for Neuroblastoma. AACR 2008 Annual Meeting, San Diego, CA